The company is bullish about its prospects in the second half of the year, despite ongoing economic and geopolitical ...

Q2 2025 Earnings Call July 29, 2025 3:00 PM ETCompany ParticipantsMichael R. Archer - Executive VP & CFORenée D.

Teva anticipates EBITDA recovery post-2025 as Austedo and Uzedy grow and generic Revlimid faces rising competition.

Universal Health Services beat Q2 earnings and raised full-year guidance, but growth concerns in behavioral health weighed on ...

Expro Group Holdings N.V. ( NYSE: XPRO) Q2 2025 Earnings Conference Call July 29, 2025 11:00 AM ET Chad Stephenson - Director of Investor Relations Michael Jardon - President, CEO & Executive Director ...

Corning Inc. forecasts strong third-quarter core sales driven by AI demand for optical connectivity products, surpassing Wall Street estimates. Learn more about their growth trends and key market ...

Q2 2025 Earnings Call Transcript July 25, 2025 Sensient Technologies Corporation beats earnings expectations. Reported EPS is ...

The deal, of course, did not end up working out, with Pippen moved elsewhere and Boston entering its wilderness era.